1. Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor. Issue 6 (17th November 2020) Authors: Joshi, Samit R.; Fernando, Disala; Igwe, Stephanie; McKenzie, Litza; Krishnatry, Anu S.; Halliday, Fiona; Zhan, Joyce; Greene, Thomas J.; Xu, Jianfeng; Ferron‐Brady, Geraldine; Lataillade, Max; Min, Sherene Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗